Production (Stage)
WELL Health Technologies Corp.
WHTCF
$2.92
-$0.073-2.44%
OTC PK
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | 48.46% | -25.21% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 48.46% | -25.21% | |||
Cost of Revenue | 13.30% | 6.23% | |||
Gross Profit | 178.39% | -64.28% | |||
SG&A Expenses | 20.36% | -3.43% | |||
Depreciation & Amortization | -9.06% | 16.88% | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 13.58% | 3.85% | |||
Operating Income | 106.71% | -405.68% | |||
Income Before Tax | 17.19% | 33.73% | |||
Income Tax Expenses | 93.71% | -1,807.85% | |||
Earnings from Continuing Operations | -28.76% | 59.19% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -124.42% | 435.38% | |||
Net Income | -249.36% | 84.40% | |||
EBIT | 106.71% | -405.68% | |||
EBITDA | 144.41% | -241.73% | |||
EPS Basic | -212.29% | 82.66% | |||
Normalized Basic EPS | 71.24% | -3,736.67% | |||
EPS Diluted | -171.87% | 79.87% | |||
Normalized Diluted EPS | 71.24% | -3,736.67% | |||
Average Basic Shares Outstanding | 11.92% | -10.04% | |||
Average Diluted Shares Outstanding | 11.92% | -10.04% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |